We Think Shareholders May Want To Consider A Review Of Bamboos Health Care Holdings Limited's (HKG:2293) CEO Compensation Package

Key Insights

• Bamboos Health Care Holdings' Annual General Meeting to take place on 28th of November
• Total pay for CEO Winsome Hai includes HK$2.52m salary
• Total compensation is 48% above industry average
• Bamboos Health Care Holdings' EPS declined by 33% over the past three years while total shareholder loss over the past three years was 6.5%

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

The results at Bamboos Health Care Holdings Limited (HKG:2293) have been quite disappointing recently and CEO Winsome Hai bears some responsibility for this. Shareholders can take the chance to hold the board and management accountable for the unsatisfactory performance at the next AGM on 28th of November. They will also get a chance to influence managerial decision-making through voting on resolutions such as executive remuneration, which may impact firm value in the future. The data we present below explains why we think CEO compensation is not consistent with recent performance.

Check out our latest analysis for Bamboos Health Care Holdings

How Does Total Compensation For Winsome Hai Compare With Other Companies In The Industry?

At the time of writing, our data shows that Bamboos Health Care Holdings Limited has a market capitalization of HK$217m, and reported total annual CEO compensation of HK$3.0m for the year to June 2025. That's a modest increase of 7.3% on the prior year. In particular, the salary of HK$2.52m, makes up a huge portion of the total compensation being paid to the CEO.

In comparison with other companies in the Hong Kong Healthcare industry with market capitalizations under HK$1.6b, the reported median total CEO compensation was HK$2.0m. Hence, we can conclude that Winsome Hai is remunerated higher than the industry median. What's more, Winsome Hai holds HK$146m worth of shares in the company in their own name, indicating that they have a lot of skin in the game.

Speaking on an industry level, nearly 80% of total compensation represents salary, while the remainder of 20% is other remuneration. Bamboos Health Care Holdings is largely mirroring the industry average when it comes to the share a salary enjoys in overall compensation. If salary dominates total compensation, it suggests that CEO compensation is leaning less towards the variable component, which is usually linked with performance.

A Look at Bamboos Health Care Holdings Limited's Growth Numbers

Over the last three years, Bamboos Health Care Holdings Limited has shrunk its earnings per share by 33% per year. In the last year, its revenue is down 22%.

Overall this is not a very positive result for shareholders. And the fact that revenue is down year on year arguably paints an ugly picture. So given this relatively weak performance, shareholders would probably not want to see high compensation for the CEO. We don't have analyst forecasts, but you could get a better understanding of its growth by checking out this more detailed historical graph of earnings, revenue and cash flow.

Has Bamboos Health Care Holdings Limited Been A Good Investment?

Given the total shareholder loss of 6.5% over three years, many shareholders in Bamboos Health Care Holdings Limited are probably rather dissatisfied, to say the least. This suggests it would be unwise for the company to pay the CEO too generously.

In Summary...

Not only have shareholders not seen a favorable return on their investment, but the business hasn't performed well either. Few shareholders would be willing to award the CEO with a pay raise. At the upcoming AGM, the board will get the chance to explain the steps it plans to take to improve business performance.

CEO compensation is an important area to keep your eyes on, but we've also need to pay attention to other attributes of the company. We identified 3 warning signs for Bamboos Health Care Holdings (1 is concerning!) that you should be aware of before investing here.

Switching gears from Bamboos Health Care Holdings, if you're hunting for a pristine balance sheet and premium returns, this free list of high return, low debt companies is a great place to look.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.